Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jean Lankoande"'
Autor:
Nebnomyidboumbou Norbert Wences Djiguemde, Timongo Francoise Danielle Millogo Traore, Jean Lankoande, Dalenda Chanouffi Cheli, Ezzidine Sfar
Publikováno v:
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 11:332
Background: Study IMGs in the 2nd or 3rd trimester of pregnancy in department “A” of the CMNT.Methods: Descriptive and analytical cross-sectional study in the “A” obstetrics gynecology department of the CMNT from January to June 2012. The var
Autor:
Isabelle Bicaba, Moumouni Bonkoungou, Eva Bazant, Jean Lankoande, Timothee Fruhauf, Gahan Furlane, Yacouba Ouedraogo, Tsigue Pleah, Ousmane Badolo
Publikováno v:
Global Health: Science and Practice. 6:288-298
Background Cervical cancer accounts for 23% of cancer incidence and 22% of cancer mortality among women in Burkina Faso. These proportions are more than 2 and 5 times higher than those of developed countries, respectively. Before 2010, cervical cance
Autor:
Ronbinson Enow Mbu, Yao Raphaël Abauleth, Akpadza Koffi, Namory Keita, Amadou Dolo, Jean Lankoande
Publikováno v:
Open Journal of Obstetrics and Gynecology. :42-46
The aim of this study was to evaluate the effectiveness of a pharmaceutical grade isoflavone supplement (Inoclim?) 40 mg per capsule of soy extract rich in daidzin and genistin) on the number of hot flashes and night sweats in menopausal African wome
Autor:
Thieba, Blandine, Adama Z, Ouattara, Angela, Coral, Cisse, Hassane, Hien, Clotaire, Blami, Dao, Jean, Lankoande, Ayisha, Diop, Jennifer, Blum
Publikováno v:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 119(2)
To explore 400-μg sublingual misoprostol as primary treatment in lower-level facilities with no previous experience providing postabortion care.Women presenting with incomplete abortion were offered a single dose of 400-μg sublingual misoprostol. I